Tumor inhibitory effect of a new series of methanesulfonate of aminoglycols.
D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical; D005260:Female; D006018:Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008113:Liver Neoplasms / Q000188:drug therapy*; D008698:Mesylates / Q000008:administration & dosage / Q000627:therapeutic use*; D009374:Neoplasms, Experimental; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy*
D000588:Amines; D000970:Antineoplastic Agents; D006018:Glycols; D008698:Mesylates